Burkehill Global Management’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
Other funds holding RNAM
Burkehill Global Management's RNAM Position: Q1 2026 in Review
Burkehill Global Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 60,000 shares — an estimated $4.33M sold.
Burkehill Global Management first reported a position in RNAM in Q3 2025 and held it in 2 quarters. The position peaked at $4.33M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- Burkehill Global Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- Burkehill Global Management sold 60,000 Avidity Biosciences shares in Q1 2026, an estimated $4.33M.
- Burkehill Global Management first reported a position in Avidity Biosciences in Q3 2025 and held it in 2 quarters.
- Burkehill Global Management's Avidity Biosciences position peaked at $4.33M in Q4 2025.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on Burkehill Global Management's 13F filing for Q1 2026, filed 15 May 2026.